Ebiox Q3 Trading Update

 

TIDMHCEG 
 
RNS Number : 0979D 
Healthcare Enterprise Group PLC 
26 November 2009 
 

 
 
 
 
 
 
 
 
26 November 2009 
 
 
Healthcare Enterprise Group PLC 
 
 
("Healthcare Enterprise" or the "Group") 
 
 
Ebiox announces sales growth of 53% in Q3 and launch of new products 
 
 
Healthcare Enterprise (AIM: HCEG), an international healthcare group, is pleased 
to announce that Ebiox Limited, in which it holds a 20% interest, has reported 
sales growth of 53% in the three months to September 2009, as compared to the 
same period last year, following a GBP800,000 cash injection by private 
investors, including Nigel Wray. 
 
 
The July to September 09 quarter was the first under Ebiox' new management, 
headed by John Honey, formerly Senior VP at Reckitt Benckiser plc. 
 
 
Highlights: 
  *  Sales up 53% on the same period last year following revenue growth of hand & 
  surface cleaning products 
  *  Launch of new biodegradable, macerator-friendly, hard surface antimicrobial wipe 
  *  Pipeline of new products includes a non alcohol-based sanitising foam hand rub 
 
The new Trionic D biodegradable wipes contain the same proven Ebiox Trionic 
formulation to clean and disinfect medical devices and hard surfaces, removing 
biofilms and providing a broad efficacy in removing and killing harmful 
pathogens. They use a high wet strength cellulose fibre sheet which is fully 
biodegradable and can be disposed of after use through a macerator unit within a 
Hospital sluice room thus avoiding the need to dispose of within a clinical 
waste stream. 
 
 
Great Ormond Street Hospital has just completed a successful six month trial of 
the disinfectant wipes and Ebiox is currently engaged in discussions with other 
potential customers, while also seeking to extend the use of the Ebiox Trionic 
formulation to other healthcare and hygiene applications. 
 
 
Ebiox Esense is a non alcohol based hand rub. The product has a broad range 
antimicrobial efficacy and is fully compliant to the required European efficacy 
standards for hygienic hand rubs used in medical environments. The formulation 
is also Chlorhexidine and Triclosan free and encourages frequent use so as to 
protect users against potential cross contamination issues and as a defense in 
many situations arising from public places. 
 
 
Lyndon Gaborit, Executive Deputy Chairman of Healthcare Enterprise, commented: 
 
 
"We are delighted with the sales growth announced by Ebiox today. Whilst we have 
seen some increased demand as a result of concerns about swine flu, Ebiox has 
under its dedicated new management and with additional funding, displayed strong 
growth and is developing a solid pipeline of new products." 
 
 
 
 
For further information, please contact: 
 
 
+-----------------------------------------+------------------------------+ 
| Healthcare Enterprise Group PLC         | Tel: [phone]           | 
| Lyndon Gaborit                          |                              | 
|                                         |                              | 
+-----------------------------------------+------------------------------+ 
| Ebiox                                   | Tel: [phone]           | 
| John Honey                              |                              | 
|                                         |                              | 
+-----------------------------------------+------------------------------+ 
| PD Marketing                            | Tel: [phone]           | 
| Dan Dullaghan                           |                              | 
|                                         |                              | 
+-----------------------------------------+------------------------------+ 
| Bishopsgate Communications              | Tel: [phone]           | 
| Robyn Samuelson / Giang Nguyen          |                              | 
|                                         |                              | 
+-----------------------------------------+------------------------------+ 
Note to Editors 
 
 
Healthcare Enterprise 
 
 
Healthcare Enterprise Group PLC (HCEG) is a healthcare investment group which 
invests in synergistic products and services within the healthcare industry. It 
currently has two main investments: 
 
 
  *  Ebiox Limited - Patented decontamination and disinfectant products that are safe 
  and alcohol free but substantially more effective than conventional methods at 
  destroying embedded microorganisms. The Ebiox range includes hand hygiene 
  products, surface disinfectants and products to clean and decontaminate surgical 
  instruments. HCEG owns 20% of Ebiox Limited. 
 
 
 
  *  Reproductive Sciences Limited - Innovative slow release pump for intrauterine 
  insemination, proven to significantly enhance pregnancy success rates. HCEG owns 
  27% of the Company. 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTFEAFMISUSEIF